首页> 外文OA文献 >Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

【2h】

Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

机译：择期经皮冠状动脉介入治疗的依诺肝素与普通肝素对比1年的结果（STEP）（依诺肝素在经皮冠状动脉介入治疗患者中的安全性和有效性，国际随机评估）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Montalescot Gilles; Gallo Richard; White Harvey D.; Cohen Marc; Steg Ph. Gabriel; Aylward Philip E.G.; Bode Christoph; Chiariello Massimo; King Spencer B.; Harrington Robert A.; Desmet Walter J.; Macaya Carlos; Steinhubl Steven R.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. [J] . White HD, Gallo R, Cohen M, The American heart journal . 2009,第1期

机译：静脉依诺肝素在肾功能不全患者的选择性经皮冠状动脉介入治疗中的应用：依诺肝素对PCI患者的安全性和有效性，一项国际随机评估（STEEPLE）试验。
2. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. [J] . White HD, Aylward PE, Gallo R, The American heart journal . 2010,第1期

机译：一项选择性的经皮冠状动脉介入治疗患者的至少5 cm血肿和预后：依诺肝素对PCI患者的安全性和有效性的见解，一项国际随机评估（STEEPLE）试验。
3. Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention [J] . Ji Huang, Nan Li, Zhao Li, 中华医学杂志（英文版） . 2018,第007期

机译：选择性经皮冠状动脉介入治疗期间糖尿病合并复杂冠状动脉疾病的低剂量普通肝素与依诺肝素序贯治疗
4. Evaluation of Oxidized Low-Density Lipoprotein in the Coronary Circulation of Patients with Coronary Artery Disease, and its Association with Percutaneous Coronary Intervention [C] . M.M. Ramadan, M. Kodama, S. Hirono, International Congress on Coronary Artery Disease . 2007

机译：冠状动脉疾病患者冠状动脉循环中氧化低密度脂蛋白的评价及其与经皮冠状动脉介入的关联
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis [O] . Johanne Silvain, Farzin Beygui, Olivier Barthélémy, 2012

机译：依诺肝素与普通肝素经皮冠状动脉介入治疗的疗效和安全性：系统评价和荟萃分析
7. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial [O] . Montalescot, Gilles, Gallo, Richard, White, Harvey D, 2009

机译：选择性经皮冠状动脉介入治疗中依诺肝素与普通肝素的比较1年的结果（STEP）（依诺肝素在经皮冠状动脉介入治疗患者中的安全性和有效性，国际随机评估）试验

Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

著录项

相似文献

相关主题

期刊订阅